Patient Power®
Get Email Alerts!
Health Topics
Search by Keyword:
Search by Health Topic:
View all Health Topics >
Spring Survey 2012 Results
Browse Programs: by Health Topic | by Date | by Expert | by Sponsor

Programs > by Expert > Michael Deininger, M.D., Ph.D.

Please use the links below to search by the first letter of a expert's last name or use the tabs above to browse by health topic, date or sponsor.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Can't find what you're looking for? Try our search engine or view all Medical Experts.

Michael Deininger, M.D., Ph.D. Michael Deininger, M.D., Ph.D.
Chief of Hematology and Hematologic Malignancies
University of Utah, Huntsman Cancer Institute

Michael Deininger, MD, PhD, is chief of Hematology and Hematologic Malignancies for Huntsman Cancer Institute (HCI) at the University of Utah. He is a professor in the Department of Medicine at the University of Utah. Deininger's clinical interests center on leukemia, myeloproliferative neoplasms and hematopoietic stem cell transplantation. His research focuses on the biology of leukemia and development of molecularly targeted therapies for hematologic malignancies. The major focus of his lab is the molecular basis of resistance to tyrosine kinase inhibitors such as imatinib, a drug used to treat chronic myeloid leukemia and some other types of cancer. They are currently developing biomarker strategies to predict both response and resistance to tyrosine kinase inhibitor therapy. Before joining HCI, Deininger served as chief of the Hematologic Malignancies Section and as leader of the Hematologic Malignancies Program at the Knight Cancer Institute at Oregon Health & Sciences University. He earned his medical degree at the University of Würzburg, Germany, with internship at the Marienhospital Aachen, Germany. He completed his residency in internal medicine as well as a fellowship in hematology and oncology at the Institute of Medical Oncology and Haematology of Nürnberg General Hospital, Germany. After earning his PhD in leukemia biology from Imperial College, London, Deininger completed an additional clinical fellowship in bone marrow transplantation in the Department of Hematology at the University of Leipzig, Germany.

Learn more about Michael Deininger, M.D., Ph.D.

Programs:
12/06/2008 - News from ASH: Updates on CML Program Details >>
Videos:
Stem Cell Transplant for Accelerated Phase CML Watch Now >>
Exploring Disease Risk and Treatment Options for CML Watch Now >>
Neuste Entwicklungen zur CML von der ASH 2011 Watch Now >>

Back to Program Replay Library | Back to by Programs Expert